| Members |
targetComponentId |
| Epiphysial fracture |
Fracture configurations (morphologic abnormality) |
| Epiphysiodesis (& [permanent cross union] or [Phemister]) |
Epiphysiodesis |
| Epiphysiodesis (& [permanent cross union] or [Phemister]) |
Phemister epiphysiodesis |
| Epiphysiodesis (& [permanent cross union] or [Phemister]) |
Cross-union epiphysiodesis |
| Epiphysiodesis: [NOS] or [NEC] |
Epiphysiodesis |
| forstyrrelse vedr. epifyselukning |
Disorder of bone development (disorder) |
| forstyrrelse af epifysedannelse |
Disorder of bone development (disorder) |
| Epiphysis of base of first metacarpal |
Structure of ossification center of base of first metacarpal (body structure) |
| Epiphysis of base of first metacarpal |
Entire base of first metacarpal bone |
| Epiphysis of base of first metacarpal |
Structure of base of first metacarpal bone |
| Epiphysis of base of first metatarsal |
Structure of base of first metatarsal bone |
| Epiphysis of base of first metatarsal |
Structure of ossification center of base of first metatarsal (body structure) |
| Epiphysis of base of first metatarsal |
Entire base of first metatarsal bone |
| Epiphysis of fifth metacarpal head |
Entire head of fifth metacarpal bone |
| Epiphysis of fifth metacarpal head |
Structure of head of fifth metacarpal bone |
| Epiphysis of fifth metacarpal head |
Structure of ossification center of head of fifth metacarpal (body structure) |
| 5. metatarsalknogles epifyse |
Structure of ossification center of fifth metatarsal head (body structure) |
| 5. metatarsalknogles epifyse |
Structure of head of fifth metatarsal bone |
| 5. metatarsalknogles epifyse |
Entire head of fifth metatarsal bone |
| Epiphysis of fourth metacarpal head |
Entire head of fourth metacarpal bone |
| Epiphysis of fourth metacarpal head |
Structure of head of fourth metacarpal bone |
| Epiphysis of fourth metacarpal head |
Structure of ossification center of head of fourth metacarpal (body structure) |
| Epiphysis of fourth metatarsal head |
Entire head of fourth metatarsal bone |
| Epiphysis of fourth metatarsal head |
Structure of ossification center of fourth metatarsal head (body structure) |
| Epiphysis of fourth metatarsal head |
Structure of head of fourth metatarsal bone |
| epifyse af caput på metakarpalknogle |
Structure of ossification center of metacarpal head (body structure) |
| epifyse af caput på metakarpalknogle |
Entire head of metacarpal bone |
| epifyse af caput på metakarpalknogle |
Structure of head of metacarpal bone |
| epifyse af caput på metatarsalknogle |
Entire head of metacarpal bone |
| epifyse af caput på metatarsalknogle |
Structure of head of metacarpal bone |
| epifyse af caput på metatarsalknogle |
Structure of ossification center of metatarsal head (body structure) |
| Epiphysis of second metacarpal head |
Structure of head of second metacarpal bone |
| Epiphysis of second metacarpal head |
Structure of ossification center of head of second metacarpal (body structure) |
| Epiphysis of second metacarpal head |
Entire head of second metacarpal bone |
| epifyse af caput på 2. metatarsalknogle |
Structure of ossification center of second metatarsal head (body structure) |
| epifyse af caput på 2. metatarsalknogle |
Structure of head of second metatarsal bone |
| epifyse af caput på 2. metatarsalknogle |
Entire head of second metatarsal bone |
| Epiphysis of third metacarpal head |
Structure of ossification center of head of third metacarpal (body structure) |
| Epiphysis of third metacarpal head |
Structure of head of third metacarpal bone |
| Epiphysis of third metacarpal head |
Entire head of third metacarpal bone |
| Epiphysis of third metatarsal head |
Structure of ossification center of third metatarsal head (body structure) |
| Epiphysis of third metatarsal head |
Entire head of third metatarsal bone (body structure) |
| Epiphysis of third metatarsal head |
Structure of head of third metatarsal bone |
| Omentorafi |
Repair of omentum |
| Omentorafi |
Suture of omentum |
| epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Epirubicin hydrochloride 2mg/mL injection solution 25mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Epirubicin hydrochloride 50mg/25 mL solution |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| epirubicinhydrochlorid 50 mg/25 ml injektionsvæske |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Episclera |
Entire lamina episcleralis |
| Episclera |
Structure of lamina episcleralis |
| Episkleral injektion |
Episcleral hyperaemia |
| Episioperineorrhaphy |
Episioperineorrhaphy |
| Episioperineorrhaphy |
Episioperineoplasty |
| Episiotomy scissors, single-use |
Episiotomy scissors |
| Episode of |
Episodic |
| Episode of |
Episode of |
| episodisk akut alkoholintoksikation ved alkoholisme |
Acute alcohol intoxication |
| episodisk akut alkoholintoksikation ved alkoholisme |
Alcohol dependence |
| episodiske flashbacks |
Intense, involuntary re-experiences of past traumatic events, often vividly bringing back sensory, emotional, and physical aspects of the original trauma. These episodes can make a person feel as though they are reliving the trauma in the present moment, accompanied by strong emotional and physical reactions. Such dissociative reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings. Flashbacks are a key symptom of PTSD (post-traumatic stress disorder) and can be triggered by reminders of the traumatic event. |
| episodiske flashbacks |
A rare disorder characterized by recurring, often distressing, visual disturbances that resemble the effects of hallucinogenic drugs. These disturbances, which can include flashes of color, geometric patterns, and afterimages, occur long after the use of hallucinogens has ceased, and can significantly impact daily functioning and quality of life. |
| Epispadias |
Epispadias (disorder) |
| Epispadias |
Male epispadias (disorder) |
| Epispadias repair (& [Denis Browne] or [Young-Dees]) |
Epispadias repair |
| Epispadias repair (& [Denis Browne] or [Young-Dees]) |
Male epispadias repair |
| Epispadias repair (including male) |
Epispadias repair |
| Epithelial hyperplasia |
Focal epithelial hyperplasia of mouth |
| Epithelial hyperplasia |
Epithelial hyperplasia of skin |
| Epitelial inklusionscyste |
Epidermoid cyst (morphologic abnormality) |
| Epitelial inklusionscyste |
Epithelial inclusion cyst (morphologic abnormality) |
| Epiteliit |
Disorder of cornea (disorder) |
| Epithelio-exfoliative colitis and deafness syndrome |
Sensorineural hearing loss |
| Epithelio-exfoliative colitis and deafness syndrome |
Colitis |
| Epiteloidt hæmangiom med involvering af øre |
Epithelioid hemangioma of skin (disorder) |
| Epithelioid hemangioma of skin |
Kimura's disease (disorder) |
| Epithelioid hemangioma of skin |
Epithelioid hemangioma of skin (disorder) |
| Epizootic disease virus of deer subgroup |
Epizootic hemorrhagic disease virus (organism) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,7 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,9 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 10.000 enheder/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 20000unt/mL injection |
Epoetin alfa 20000 unit/mL solution for injection |
| Epoetin alfa 20000unt/mL solution |
Epoetin alfa 20000 unit/mL solution for injection |
| epoetin alfa 2000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 3000unt/mL injection |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 3000unt/mL solution |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa 40.000 IE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Epoetin alfa 40000 unit/mL solution for injection |
| epoetin alfa 4000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin alfa 5000iu/0.5mL prefilled syringe |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 6000iu/0.6mL prefilled syringe |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 7000iu/0.7mL prefilled syringe |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 8000iu/0.8mL prefilled syringe |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 9000iu/0.9mL prefilled syringe |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 10.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
Product containing precisely epoetin beta 16667 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 1000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Epoetin beta 3333 unit/mL solution for injection |
| epoetin beta 2000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely epoetin beta 6667 unit/1 milliliter conventional release solution for injection (clinical drug) |
FHIR